Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® HIV / AIDS specialty page provides HIV/AIDS-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Long-Acting Injectable ART: Benefits & Misconceptions
Joseph Eron, MD, discusses benefits of long-acting injectable antiretroviral therapy as well as misconceptions.
Battling Resistance to HIV Therapy: New Drugs in the Pipeline
Joseph Eron, MD, explains how some individuals acquire resistance to HIV therapy and discusses new drugs in the pipeline that are effective against resistant virus.
What Can Physicians Do If Their Patient Declines Getting Tested for HIV?
Colleen Kelley, MD, stresses the importance of routinizing HIV testing and shares what physicians can do if their patient declines the option to get tested.
When Can Clinicians Expect Long-Acting Injectable ART?
Joseph Eron, MD, discusses when clinicians may expect to have access to long-acting injectable ART and the different opportunities it offers for individuals with HIV.
What Can Be Done to Get More Individuals Tested for HIV?
Colleen Kelley, MD, explains what is needed to ensure that individuals get tested for HIV.
Rapid Entry Programs In South Prove Successful at Improving Access to HIV Care and Viral Suppression
Jonathan Colasanti, MD, MSPH, shares how the introduction of a Rapid Entry Program in Atlanta proved successful at improving access to HIV care and viral suppression rates.
Are There Any Risks Associated with Raltegravir HD?
Pedro Cahn, MD, describes the risk associated with raltegravir HD.
Who is the Target Population for Raltegravir HD?
Pedro Cahn, MD, explains who the target population is for raltegravir HD.
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.